Cosmetic cross-reference

Guaiacol

CAS 90-05-1

Guaiacol (CAS 90-05-1) is a Phase 3 pharmaceutical compound with 2 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Guaiacol

CAS Number

90-05-1

UNII

6JKA7MAH9C

InChIKey

LHGVFZTZFXWLCP-UHFFFAOYSA-N

ChEMBL ID

CHEMBL13766

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3

Late-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL13766 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 8 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	Potency	12783.9 nM	15	-
-	MIC	5000000 nM	4	-
-	AC50	12177.133333333333 nM	3	-
-	Ki	31570 nM	2	-
-	IC50	19976.309999999998 nM	1	-
-	IC50	4.1 ug.mL-1	1	-
Carbonic anhydrase 2 Enzyme	Ki	5.53	-	Homo sapiens
Carbonic anhydrase 1 Enzyme	Ki	4.22	-	Homo sapiens

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
GUAIACOL	5031	SU	MTHSPL
guaiacol	5031	IN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Guaiacol used for in pharmaceutical contexts?

Guaiacol (CAS 90-05-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Guaiacol?

No adverse-event association or SIDER side-effect rows are rendered for Guaiacol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Guaiacol also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Guaiacol with EU status "permitted".

What clinical phase is Guaiacol in?

Guaiacol is rendered with ChEMBL max phase 3.

What bioactivity targets are documented for Guaiacol?

Guaiacol has 8 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Carbonic anhydrase 1.